<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: bluebird bio Announces New England Journal of Medicine Publication of Interim Data from Two Phase 1/2 Clinical Studies of LentiGlobinTM Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia	</title>
	<atom:link href="https://www.novumpr.nl/2018/04/19/bluebird-bio-announces-new-england-journal-of-medicine-publication-of-interim-data-from-two-phase-12-clinical-studies-of-lentiglobintm-gene-therapy-in-patients-with-transfusion-dependent-%CE%B2-thala/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/04/19/bluebird-bio-announces-new-england-journal-of-medicine-publication-of-interim-data-from-two-phase-12-clinical-studies-of-lentiglobintm-gene-therapy-in-patients-with-transfusion-dependent-%ce%b2-thala/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bluebird-bio-announces-new-england-journal-of-medicine-publication-of-interim-data-from-two-phase-12-clinical-studies-of-lentiglobintm-gene-therapy-in-patients-with-transfusion-dependent-%25ce%25b2-thala</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Thu, 19 Apr 2018 09:02:58 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
